Magnetic Resonance Imaging and Clinical Outcomes of Laser Therapy, Ultrasound Therapy, and Extracorporeal Shock Wave Therapy for Treatment of Plantar Fasciitis: A Randomized Controlled Trial

2017 ◽  
Vol 56 (4) ◽  
pp. 762-767 ◽  
Author(s):  
Aslihan Ulusoy ◽  
Lale Cerrahoglu ◽  
Sebnem Orguc
Keyword(s):  
Magnetic Resonance Imaging ◽  
Shock Wave ◽  
Plantar Fasciitis ◽  
Controlled Trial ◽  
Extracorporeal Shock Wave Therapy ◽  
Ultrasound Therapy ◽  
Resonance Imaging ◽  
Shock Wave Therapy ◽  
Randomized Controlled ◽  
Extracorporeal Shock Wave

scholarly journals Evaluation Effects of Laser Therapy and Extracorporeal Shock Wave Therapy with Clinical Parameters and Magnetic Resonance Imaging for Treatment of Plantar Fasciitis in Patients with Spondyloarthritis: A Randomized Controlled Trial

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Kezban Armagan Alpturker ◽  
Ayse Beyhan Lale Cerrahoglu ◽  
Ihsan Sebnem Orguc
Keyword(s):  
Magnetic Resonance Imaging ◽  
Shock Wave ◽  
Magnetic Resonance ◽  
Laser Therapy ◽  
Plantar Fasciitis ◽  
Plantar Fascia ◽  
Extracorporeal Shock Wave Therapy ◽  
Resonance Imaging ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave

Objective. Low-level laser therapy (LLLT) and extracorporeal shock wave therapy (ESWT) is applied in the conservative treatment of inflammatory plantar fasciitis, which is also a characteristic feature of spondyloarthritis (SpA) (Gill, 1997 and Roxas, 2005). We determined and compared the effectiveness of LLLT and ESWT using magnetic resonance imaging (MRI). Methods. This study is a prospective, randomized, comparative, single-blind clinical study. Voluntarily followed 40 patients with the diagnosis of SpA and having pain at the heels at least for 6 months. Patients were divided randomly into two treatment groups. One group undertook 14 sessions of infrared Ga-Al-As LLLT, and the other group undertook 3 sessions ESWT. Feet functions of the patients were evaluated by American Orthopaedic Foot and Ankle Society (AOFAS) and Roles and Maudsley Scoring; VAS was evaluated for foot pain and function. In clinical assessment, disease activity was carried out by applying the BASDAI, the functional assessment was evaluated through the BASFI, and the patient quality of life was evaluated through the ASQoL; enthesitis was scored according to MASES assessment, performed before and at 1 month after treatment. The thickness of the plantar fascia was measured with MRI before and 1 month after treatment. Results. Compared with the pretherapy, progress in the feet function by AOFAS and Roles-Maudsley scoring and decrease in VAS levels were statistically significant in both groups (p<0.001). Only the VAS exercise score was superior to LLLT (p<0.05). The thickness of the plantar fascia had decreased significantly on MRI in all two groups. Conclusion. The treatment of plantar fasciitis with LLLT and ESWT was more successful in pain improvement and functional outcomes with the dose, frequency, and duration used in our study.

scholarly journals Instant analgesic effect of radial extracorporeal shock wave therapy on primary dysmenorrhoea according to functional magnetic resonance imaging: Study protocol for a randomised placebo-controlled trial

2019 ◽  
Author(s):  
Shanshan Liu ◽  
Lezheng Wang ◽  
Jian Yang
Keyword(s):  
Magnetic Resonance Imaging ◽  
Shock Wave ◽  
Magnetic Resonance ◽  
Controlled Trial ◽  
Extracorporeal Shock Wave Therapy ◽  
Functional Magnetic Resonance ◽  
Resonance Imaging ◽  
Shock Wave Therapy ◽  
Primary Dysmenorrhoea ◽  
Extracorporeal Shock Wave

Abstract Background: Primary dysmenorrhoea (PDM) is defined as a series of pain-dominated symptoms during and after menstruation without organic lesions. Non-steroidal anti-inflammatory drugs and oral contraceptives are usually recommended as first-line drugs for the clinical treatment of PDM, but their widespread long-term application is controversial. Radial extracorporeal shock wave therapy (rESWT) has been widely applied in musculoskeletal rehabilitation because of its secure and non-invasive characteristics and its confirmed effect in improving pain symptoms. This research seeks to explore the efficacy of rESWT for PDM and the changes in brain function of patients with PDM. Methods: This clinical research will be a randomised, evaluated blind and sham-controlled trial. Forty-six patients with PDM will be divided into the rESWT group (n = 23) and the sham rESWT group (n = 23) at random. In the rESWT group, treatment will be applied once within 48 hours of menstruation at six abdominal myofascial trigger points. The sham rESWT group will receive sham shockwave therapy on the same sites but without energy input. Other dysmenorrhoea-related treatments in both groups will be limited. The main indicators include the short-form McGill Pain Questionnaire and the Cox Menstrual Symptom Scale. The secondary indicators include the Zung Self-rating Anxiety Scale and Self-rating Depression Scale and functional magnetic resonance imaging (fMRI) changes in brain regions. Results will be evaluated at the screening, baseline and before and after treatment, and adverse treatments will be examined. Inter- and intra-group analyses will be performed in the statistics section. Discussion: This randomised controlled study is designed to explore the immediate efficacy of rESWT for PDM. After rESWT treatment, PDM symptom tests, pain tests as well as fMRI data will be investigated for the potential connections between immediate neuroanalgesic mechanisms, which are associated with pain and brain networks. The main results will be used to assess the efficacy of rESWT, and secondary results will focus on improving the neurobiological understanding of disease treatment.

Sign in / Sign up

Export Citation Format

Share Document